Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 12,501–12,525 of 27,380 studies, newest first · page 501 of 1096.

September 2019 22

  1. 2019-09-04

    The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy “In Vivo” in the Differential Diagnosis of Alzheimer’s Dementia

    ✓ Peer-reviewed Biomarkers Current Alzheimer Research

    Key finding: It might constitute a simple, cost-effective and reproducible in vivo proxy of AD suitable to be adopted worldwide not only in daily clinical practice but also in future experimental trials, to avoid the enrolment of misdiagnosed AD patients.

  2. 2019-09-04

    Hearing loss and Alzheimer's disease: A Review

    ✓ Peer-reviewed Risk factors The international tinnitus journal

    Key finding: The mechanisms and causal relationship of this association are still partially unknown, and several theories have been proposed. +4 more findings

  3. 2019-09-04

    Longitudinal analysis of dementia diagnosis and specialty care among racially diverse Medicare beneficiaries

    ✓ Peer-reviewed Costs and economics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Ascertainment of etiologic dementia subtype may inform hereditary risk and facilitate financial and care planning. +1 more finding

  4. 2019-09-04

    Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

    ✓ Peer-reviewed Clinical safety Translational neurodegeneration

    Key finding: A wealth of experimental evidence has linked this relatively small but ubiquitously expressed protein to a plethora of cytopathologic mechanisms and suggests that aSyn may be capable of seeding the progressive spread of synucleinopathy throughout the brain. +1 more finding

  5. 2019-09-04

    Can Hearing Aids Delay Time to Diagnosis of Dementia, Depression, or Falls in Older Adults?

    ✓ Peer-reviewed Clinical safety Journal of the American Geriatrics Society

    Key finding: Use of HAs is associated with delayed diagnosis of AD, dementia, depression, anxiety, and injurious falls among older adults with HL. +1 more finding

  6. 2019-09-04

    Neuroinflammatory Processes, A1 Astrocyte Activation and Protein Aggregation in the Retina of Alzheimer's Disease Patients, Possible Biomarkers for Early Diagnosis

    ✓ Peer-reviewed Inflammation and the immune system Frontiers in neuroscience

    Key finding: It is commonly thought that the lack of early diagnostic criteria is among the main causes of pharmacological therapy and clinical trials failure; therefore, the actual challenge is to define new biomarkers and non-invasive technologies to measure neuropathological changes in vivo at pre-symptomatic stages. +3 more findings

  7. 2019-09-04

    Impact of Project ECHO Models of Medical Tele-Education: a Systematic Review

    ✓ Peer-reviewed Disparities Journal of general internal medicine

    Key finding: The number of studies examining ECHO and ECHO-like models of medical tele-education has been modest compared with the scope and scale of implementation throughout the USA and internationally. +2 more findings

  8. 2019-09-04

    Dementia in China: epidemiology, clinical management, and research advances

    ✓ Peer-reviewed Getting a diagnosis The Lancet. Neurology

    Key finding: The number of clinical trials of Chinese and western medicines has substantially increased as a result of progress in research on new antidementia drugs but international multicentre studies are few in number.

  9. 2019-09-03

    Mobile applications to detect hearing impairment: opportunities and challenges

    ✓ Peer-reviewed Cognitive tests and assessment Bulletin of the World Health Organization

    Hearing loss affects close to 1.3 billion people and is a growing global health concern as the fourth leading contributor to years lived with disability. 1 The global economic cost associated with hearing loss is estimated at 750 billion United States dollars (US$) annually.2 However, hearing loss has limited public health support, especially in low-and middle-income countries, where incidence is high and resources often scarce and unequally distributed.

  10. 2019-09-03

    Educational Program for Promoting Collaboration Between Community Care Professionals and Convenience Stores

    ✓ Peer-reviewed Risk factors Journal of Applied Gerontology

    Key finding: After the program, the total score for attitudes toward dementia ( p = .010) improved significantly among the convenience store staff. +2 more findings

  11. 2019-09-02

    TREM2 regulates obesity-induced insulin resistance via adipose tissue remodeling in mice of high-fat feeding

    ✓ Peer-reviewed TREM2 and immune genetics Journal of translational medicine

    Key finding: Adipose tissue remodeling plays a significant role in obesity-induced insulin resistance. +3 more findings

  12. 2019-09 month only

    [Anti-tau therapies-what can be expected?]

    ✓ Peer-reviewed Drug development Der Nervenarzt

    Key finding: Alzheimer's disease is histopathologically characterized by aggregation of two proteins, namely amyloid-beta peptide and tau protein. +2 more findings

  13. 2019-09-01

    Sex differences in the genetic predictors of Alzheimer's pathology

    ✓ Peer-reviewed Genetics Brain : a journal of neurology

    Key finding: In follow-up analyses, rs34331204 was also associated with hippocampal volume, executive function, and age-at-onset only among males. +1 more finding

  14. 2019-09-01

    What do relatives value most in end-of-life care for people with dementia?

    ✓ Peer-reviewed End-of-life care International journal of palliative nursing

    Key finding: Experiences translated into four themes: acknowledging human dignity; being recognised as an important caregiver; (not) talking about death and dying and making decisions together. +4 more findings

  15. 2019-09-01

    159 Geographic Accessibility and Capacity of Day Care Services for People with Dementia

    ✓ Peer-reviewed Risk factors Age and Ageing

    Key finding: Day care has a place in the menu of service for people with dementia living in the community.

  16. 2019-09-01

    [New biomarkers for Alzheimer's disease in cerebrospinal fluid and blood]

    ✓ Peer-reviewed Tau biomarkers Der Nervenarzt

    Key finding: Several studies have clearly shown that determination of the amyloid beta 42 to amyloid beta 40 peptide ratio is superior to the interpretation of amyloid beta 42 alone and should be implemented in the clinical work-up; however, in recent years different studies have presented many other innovative CSF and blood-based biomarkers. +2 more findings

  17. 2019-09-01

    Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study

    ✓ Peer-reviewed Digital health tools Brain : a journal of neurology

    Key finding: Multiple logistic regression analysis revealed increased likelihood of multiple system atrophy versus Lewy body disease and progressive supranuclear palsy if a patient developed orthostatic hypotension or urinary incontinence with the requirement for urinary catheters [multiple system atrophy versus Lewy body disease: odds ratio (OR): 2.0, 95% confidence interval (CI): 1.1-3.7, P = 0.021; multiple system atrophy versus progressive supranuclear palsy: OR: 11.2, 95% CI: 3.2-39.2, P < 0.01]. +1 more finding

  18. 2019-09-01

    The Self-Care Needs and Behaviors of Dementia Informal Caregivers: A Systematic Review

    ✓ Peer-reviewed Disparities The Gerontologist

    Key finding: Three themes emerged from 29 included studies: self-care needs and behaviors of ICGs, barriers to performing self-care, and enablers of self-care.

  19. 2019-09-01
  20. 2019-09-01

    Association of Midlife Hearing Impairment With Late-Life Temporal Lobe Volume Loss

    ✓ Peer-reviewed Brain scans and imaging JAMA otolaryngology-- head & neck surgery

    Key finding: The findings suggest that midlife HI is a risk factor for temporal lobe volume loss. +4 more findings

  21. 2019-09-01

    Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status

    ✓ Peer-reviewed Biomarkers JAMA neurology

    Key finding: The mean (SD) age of the 842 participants in cohort 1 was 72 (5.6) years, with a range of 59 to 88 years, and 446 (52.5%) were female. +2 more findings

  22. 2019-09-01

    Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

    ✓ Peer-reviewed Biomarkers JAMA neurology

    Key finding: These data support the use of cNfL as a biomarker of neuroaxonal damage and indicate that age-specific and sex-specific (and in some cases disease-specific) reference values may be needed. +3 more findings

August 2019 3

  1. 2019-08-31

    Demands for Development of Taurine-Containing Home Meal Replacement for Prevention of Dementia According to Age

    ✓ Peer-reviewed Risk factors Advances in experimental medicine and biology

    Key finding: The level of need for EF-HMR was significantly higher in 40-49 years and 50-64 years groups compared to the elderly group (p < 0.001). +3 more findings

  2. 2019-08-30

    Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials

    ✓ Peer-reviewed Prevention and risk International journal of molecular sciences

    Key finding: A nutritional approach could be a promising strategy to prevent or slow the progression of neurodegenerative diseases such as Parkinson's and Alzheimer's disease, since there is no effective therapy for these diseases so far. +3 more findings

  3. 2019-08-30

    Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model

    ✓ Peer-reviewed Disease mechanisms Gut

    Key finding: These results indicate that microbiota-mediated intestinal and systemic immune aberrations contribute to the pathogenesis of AD in ADLP APT mice, providing new insights into the relationship between the gut (colonic gene expression, gut permeability), blood (blood immune cell population) and brain (pathology) axis and AD (memory deficits). +1 more finding

Browse the library by subject, with the full score breakdown →